$1.57 (-1.26%)

Volume: 21.05k

Closed: Jun 02, 2023

Hollow Logo Score: -2.140
Galectin Therapeutics Inc. Stock
$1.57 (-1.26%)

Volume: 21.05k

Closed: Jun 02, 2023

Score Hollow Logo -2.140
NASDAQ:GALT

Galectin Therapeutics Inc. Stock Price (Quote)

$1.57 ( -1.26% ) Friday, 2nd Jun 2023

Range Low Price High Price Comment
30 days $1.52 $1.93 Friday, 2nd Jun 2023 GALT stock ended at $1.57. This is 1.26% less than the trading day before Thursday, 1st Jun 2023. During the day the stock fluctuated 5.96% from a day low at $1.56 to a day high of $1.65.
90 days $1.52 $2.40
52 weeks $1.02 $2.57

Historical Galectin Therapeutics Inc. prices

Date Open High Low Close Volume
2023-06-02 $1.65 $1.65 $1.56 $1.57 21 050
2023-06-01 $1.60 $1.65 $1.57 $1.59 28 926
2023-05-31 $1.66 $1.69 $1.52 $1.57 130 421
2023-05-30 $1.59 $1.74 $1.59 $1.61 25 747
2023-05-26 $1.61 $1.75 $1.60 $1.60 81 438
2023-05-25 $1.80 $1.85 $1.65 $1.65 64 949
2023-05-24 $1.77 $1.82 $1.76 $1.78 16 611
2023-05-23 $1.79 $1.91 $1.78 $1.80 63 578
2023-05-22 $1.73 $1.87 $1.71 $1.82 45 977
2023-05-19 $1.62 $1.79 $1.62 $1.75 40 646
2023-05-18 $1.67 $1.70 $1.64 $1.65 29 181
2023-05-17 $1.63 $1.68 $1.62 $1.67 70 400
2023-05-16 $1.66 $1.72 $1.62 $1.62 33 352
2023-05-15 $1.75 $1.75 $1.64 $1.64 57 597
2023-05-12 $1.73 $1.80 $1.69 $1.69 29 420
2023-05-11 $1.77 $1.81 $1.74 $1.76 36 871
2023-05-10 $1.76 $1.83 $1.75 $1.81 23 742
2023-05-09 $1.85 $1.85 $1.72 $1.77 31 522
2023-05-08 $1.71 $1.93 $1.71 $1.88 91 421
2023-05-05 $1.68 $1.76 $1.66 $1.72 30 498
2023-05-04 $1.65 $1.68 $1.64 $1.65 25 626
2023-05-03 $1.71 $1.77 $1.68 $1.68 32 273
2023-05-02 $1.77 $1.83 $1.62 $1.66 53 356
2023-05-01 $1.77 $1.84 $1.71 $1.71 26 277
2023-04-28 $1.70 $1.76 $1.71 $1.76 42 319
2023-04-27 $1.75 $1.77 $1.71 $1.74 65 493
2023-04-26 $1.76 $1.83 $1.75 $1.76 31 606
2023-04-25 $1.85 $1.86 $1.75 $1.75 58 882
2023-04-24 $1.92 $1.94 $1.84 $1.84 35 866
2023-04-21 $1.94 $1.98 $1.91 $1.92 40 844
2023-04-20 $2.04 $2.04 $1.92 $1.98 55 576
2023-04-19 $1.97 $2.05 $1.96 $2.04 60 113
2023-04-18 $2.05 $2.05 $1.98 $1.98 50 248
2023-04-17 $1.99 $2.04 $1.96 $2.03 80 029
2023-04-14 $2.09 $2.10 $1.97 $2.01 37 436
2023-04-13 $2.01 $2.08 $2.01 $2.04 38 484
2023-04-12 $2.03 $2.10 $1.98 $2.04 56 161
2023-04-11 $1.97 $2.09 $1.97 $2.04 49 562
2023-04-10 $2.06 $2.11 $2.00 $2.02 54 398
2023-04-06 $2.01 $2.10 $2.01 $2.08 32 656
2023-04-05 $1.96 $2.01 $1.95 $2.01 19 944
2023-04-04 $1.91 $2.02 $1.91 $1.96 53 747
2023-04-03 $2.07 $2.09 $1.92 $1.94 84 991
2023-03-31 $2.26 $2.26 $2.06 $2.10 45 249
2023-03-30 $2.06 $2.20 $2.05 $2.17 102 967
2023-03-29 $2.03 $2.10 $1.95 $2.06 73 009
2023-03-28 $1.93 $1.99 $1.91 $1.99 25 390
2023-03-27 $1.95 $1.99 $1.92 $1.95 43 968
2023-03-24 $1.94 $1.98 $1.90 $1.96 32 600
2023-03-23 $1.99 $2.00 $1.90 $1.98 21 420
Click to get the best stock tips daily for free!

About Galectin Therapeutics Inc.

Galectin Therapeutics. Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. The company's lead product candidate is belapectin (GR-MD-02) galectin-3 inhibitor, a galactoarabino-rhamnogalacturonan polysaccharide polymer that is in Phase III clinical trial for the treatment of liver fibrosis associated with fatty liver disease and non-alcoholic steatohepatiti... GALT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT